Kyla Kennedy (Kinnick)
About Kyla Kennedy (Kinnick)
Kyla Kennedy serves as the Director at Asklepios BioPharmaceutical, Inc. since 2022, bringing extensive experience in clinical study management and research from her previous roles at various biopharmaceutical companies and the Department of Veterans Affairs.
Work at Asklepios BioPharmaceutical
Kyla Kennedy currently serves as Director at Asklepios BioPharmaceutical, Inc. (AskBio), a position she has held since 2022. In this role, she focuses on advancing the company's corporate vision through strategic management. Prior to her current title, she worked as Associate Director at AskBio for three months in 2022. Her experience at AskBio reflects her commitment to utilizing emotional intelligence to empower and support cross-functional teams.
Previous Experience in Biopharma
Kyla Kennedy has extensive experience in the biopharmaceutical industry. She worked at Theravance Biopharma US, Inc. in various roles, including Senior Clinical Study Manager from 2020 to 2021 and Associate Director of Development Operations from 2021 to 2022. Her tenure at Theravance also included positions as Clinical Study Manager and Sr. Clinical Trial Specialist, contributing to her comprehensive understanding of clinical operations.
Background in Research and Project Management
Kyla Kennedy's career began in research, where she worked as a Research Specialist at the Department of Veterans Affairs from 2008 to 2012. She also served as a Research Assistant at The University of Iowa from 2005 to 2008. In addition to her research roles, she gained project management experience at CompleWare from 2012 to 2017 and at PRA Health Sciences from 2017 to 2018, enhancing her skills in managing complex projects.
Education and Expertise
Kyla Kennedy earned a Bachelor of Arts (BA) in Psychology from the University of Iowa, where she studied from 2003 to 2007. Her educational background provides a foundation for her strong focus on emotional intelligence, which she applies to support and empower teams in her professional roles. This expertise is evident in her proactive approach to overcoming challenges and capitalizing on opportunities within the biopharmaceutical field.